KILITCH DRUGS(I)
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Kilitch Drugs(I) along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-1.51₹ -5.10
As on Dec 17, 2025, 4:01 PM IST
Kilitch Drugs(I) Price Performance
Today's LowToday's High
₹327.70₹338.05
₹332.00
52 Weeks' Low52 Weeks' High
₹278.16₹490.00
₹332.00
Open Price
₹335.30
Prev. Close
₹337.10
Volume
272
Over the last 5 years, the share price of Kilitch Drugs(I) has gained 29.28% CAGR. Over the past year, the corresponding return has been 4.39%.
Kilitch Drugs(I)’s current P/E of 21.05x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Kilitch Drugs(I) Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Kilitch Drugs(I) | -0.90 | -7.44 | -9.51 | -25.49 | 4.39 | 28.04 | 29.28 |
| Sun Pharmaceutical Industries | 0.32 | 1.60 | 10.60 | 8.68 | 0.14 | 21.96 | 25.69 |
| Divi's Laboratories | -0.03 | -3.56 | 3.97 | -3.76 | 7.56 | 23.41 | 10.46 |
| Torrent Pharmaceuticals | -0.96 | -1.58 | 6.01 | 15.51 | 11.14 | 33.01 | 22.19 |
| Cipla | 0.56 | -2.53 | -3.96 | -0.40 | 3.24 | 10.95 | 13.84 |
| Dr. Reddy's Laboratories | 1.59 | 2.13 | -3.05 | -3.64 | 1.84 | 13.05 | 4.60 |
| Lupin | 2.66 | 2.83 | 3.87 | 8.55 | 3.12 | 42.53 | 16.80 |
| Zydus Lifesciences | -0.63 | -1.76 | -11.31 | -4.28 | -5.33 | 30.89 | 14.08 |
| Mankind Pharma | -1.74 | -6.00 | -17.85 | -10.30 | -20.70 | 14.01 | 8.18 |
| Aurobindo Pharma | 1.51 | -3.89 | 8.47 | 7.17 | -2.01 | 39.53 | 6.40 |
| Alkem Laboratories | 0.29 | -1.90 | 2.54 | 16.65 | 4.19 | 23.22 | 13.84 |
| Abbott India | -1.25 | -6.50 | -10.56 | -12.97 | -1.18 | 9.86 | 11.43 |
| Glenmark Pharmaceuticals | -0.48 | 4.17 | -4.83 | 17.52 | 28.48 | 67.13 | 30.30 |
| Laurus Labs | -0.88 | -1.28 | 12.95 | 52.78 | 76.64 | 37.55 | 24.16 |
| Biocon | 2.02 | -8.24 | 9.09 | 9.66 | 10.19 | 13.70 | -3.45 |
| GlaxoSmithKline Pharmaceuticals | -0.44 | 3.57 | -5.68 | -20.67 | 13.92 | 24.68 | 10.23 |
| Anthem Biosciences | 3.03 | -0.26 | -23.13 | -9.12 | -9.12 | -3.14 | -1.89 |
| Ipca Laboratories | -5.00 | -4.91 | 6.04 | 2.52 | -10.70 | 17.64 | 5.16 |
| Ajanta Pharma | -1.89 | 4.06 | 1.69 | 2.29 | -9.32 | 30.31 | 18.76 |
| J B Chemicals & Pharmaceuticals | -1.77 | -2.36 | 5.02 | 3.09 | -2.66 | 20.00 | 26.95 |
Over the last one year, Kilitch Drugs(I) has gained 4.39% compared to peers like Sun Pharmaceutical Industries (0.14%), Divi's Laboratories (7.56%), Torrent Pharmaceuticals (11.14%). From a 5 year perspective, Kilitch Drugs(I) has outperformed peers relative to Sun Pharmaceutical Industries (25.69%) and Divi's Laboratories (10.46%).
Kilitch Drugs(I) Financials
Kilitch Drugs(I) Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 336.44 | 337.27 |
| 10 | 337.84 | 339.03 |
| 20 | 346.5 | 344.96 |
| 50 | 361.78 | 357.39 |
| 100 | 377.24 | 368.99 |
| 200 | 382.38 | 370.69 |
Kilitch Drugs(I) Share Holding Pattern
In the latest quarter, Kilitch Drugs(I) saw a drop in promoter holding to 63.77%, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding moved up to 36.22% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Kilitch Drugs(I) Corporate Actions
Date Time | Announcement |
|---|---|
| Nov 15, 2025, 2:21 AM IST | Kilitch Drugs(I) - Monitoring Agency Report |
| Nov 14, 2025, 11:22 PM IST | Kilitch Drugs(I) - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Nov 14, 2025, 12:30 AM IST | Kilitch Drugs(I) - Board Meeting Outcome for Outcome Of Board Meeting |
| Nov 14, 2025, 12:22 AM IST | Kilitch Drugs(I) - Unaudited Financial Results For The Quarter Ended 30Th September, 2025 |
| Nov 08, 2025, 8:13 PM IST | Kilitch Drugs(I) - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Statement Of The Company Fo |
About Kilitch Drugs(I)
Kilitch Drugs(I) Ltd. is a Public Limited Listed company incorporated on 12/05/1992 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH1992PLC066718 and registration number is 066718. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 181.59 Cr. and Equity Capital is Rs. 16.08 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressC-301/2, M.I.D.C., New Mumbai Maharashtra 400705
- Contact
Management
- Mr. Mukund P MehtaManaging Director
- Mr. Bhavin Mukund MehtaWhole Time Director
- Mrs. Mira B MehtaWhole Time Director
- Mr. Hemang J EngineerIndependent Director
- Mr. Venkita Subramanian RajanIndependent Director
- Prof. Vasudev Krishna MurtiIndependent Director
- Mr. Dipen J JainIndependent Director
FAQs on Kilitch Drugs(I) Share Price
What is the share price of Kilitch Drugs(I)?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Kilitch Drugs(I) is ₹332.00 as on Dec 17, 2025.
What kind of stock is Kilitch Drugs(I)?
The Kilitch Drugs(I) is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Kilitch Drugs(I)?
The market cap of Kilitch Drugs(I) is ₹580.36 Cr as on Dec 17, 2025.
What are today's High and Low prices of Kilitch Drugs(I)?
Today’s highest and lowest price of Kilitch Drugs(I) are ₹338.05 and ₹327.70.
What are the 52 Week High and 52 Week Low of Kilitch Drugs(I)?
The 52-week high/low is the highest and lowest price at which Kilitch Drugs(I) stock has traded in the past 52-week or nearly a year. The 52-week high of Kilitch Drugs(I) is ₹490.00 and 52-week low of Kilitch Drugs(I) is ₹278.16 as on Dec 17, 2025.
How has the Kilitch Drugs(I) performed historically in terms of returns?
The Kilitch Drugs(I) has shown returns of -1.51% over the past day, -7.44% for the past month, -9.51% over 3 months, 4.39% over 1 year, 28.04% across 3 years, and 29.28% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Kilitch Drugs(I)?
P/E ratio of and PB ratio of Kilitch Drugs(I) are 21.05 and 2.30 on Dec 17, 2025. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse